In contrast, mesenchymal markers (CD44, CD10, α‐SMA, FSP1) in rat valves were observed to be significantly higher in the CKD group compared to those of the CTL group, which were largely inhibited by administration of DAPT. This evidence concerns the gene CD44 and chronic kidney disease.